Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
about
Dimethyl fumarate for multiple sclerosisDimethyl fumarate for multiple sclerosisDimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapyDimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerationsOptimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of actionLaquinimod therapy in multiple sclerosis: a comprehensive reviewThe clinical potential of influencing Nrf2 signaling in degenerative and immunological disordersThe effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis.Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trialsDimethyl fumarate inhibits integrin α4 expression in multiple sclerosis modelsTime course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosisEfficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis.Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis.Dimethyl Fumarate: A Review in Relapsing-Remitting MS.Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.Sex Bias in Pathogenesis of Autoimmune Neuroinflammation: Relevance for Dimethyl Fumarate Immunomodulatory/Anti-oxidant Action.Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials.Role of Nrf2 Signaling in the Regulation of Vascular BK Channel β1 Subunit Expression and BK Channel Function in High-Fat Diet-Induced Diabetic Mice.Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.Regulation of vascular large-conductance calcium-activated potassium channels by Nrf2 signalling.The heritage of glatiramer acetate and its use in multiple sclerosisDiscontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers
P2860
Q24186433-37E2E5E8-9E2F-4E8A-8EFA-8524D1A446B6Q24197602-DA335D15-53EB-407B-BDCD-85187DD76AFEQ26738969-76A70781-B52E-4965-AA19-89D6870AE563Q26752859-B216F889-590F-4F69-A460-5A88FBFFECDBQ26822611-80C587D6-DDCB-41DF-B948-6352DB5B2969Q28086844-824301BA-610C-4AFA-9C1F-98C58BC98C48Q28395641-8953A135-EA76-4587-8382-A573A37D1D4EQ33621682-E324B0C6-9DDB-44CD-92C8-F1C34511BD65Q34577661-C7D1032A-8F3B-4C33-A30C-703F39B3EBF2Q34667496-4E33BDF3-5F73-4A81-8883-F0F1E51AD46DQ35115898-705D1661-8E17-4BA3-87CB-111046D889FFQ36154808-3C70A0C9-3E20-4596-B41A-4A2BA322C56CQ36361543-583C49A5-C664-4F20-BC00-36D347640F77Q37343648-978D8EDB-D2CB-4B24-BF71-2A507BB49FCBQ38195521-13EA707A-6AA0-435D-B88E-5D3E97AEA6CAQ38675014-6D91AE3C-FE4D-429B-BA56-1A603C007242Q39100528-0E766BDA-81B6-4282-BD0E-23F76EE023FCQ40189763-C3147964-2C1F-40BD-A32C-BEC39C20E987Q40425312-724E53FB-1010-4165-9904-DF0397CCD640Q41197212-F8858520-8F29-4224-A5FE-FCE0DED1AD4AQ41972825-D868353B-3967-423C-99B9-7351E54EC75FQ46760321-7E595EA8-5E44-4B5B-AFCD-96AC48D64E08Q51042757-1B4FAF12-943D-4AC3-8560-D95AF712ABAEQ56804781-38EC8346-7085-4F1B-B687-E528CAAE0F17Q58805531-6E7BF075-645D-483D-B382-36D946F0EDD9
P2860
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Clinical efficacy of BG-12 (di ...... analyses of the CONFIRM study.
@en
Clinical efficacy of BG-12
@nl
type
label
Clinical efficacy of BG-12 (di ...... analyses of the CONFIRM study.
@en
Clinical efficacy of BG-12
@nl
prefLabel
Clinical efficacy of BG-12 (di ...... analyses of the CONFIRM study.
@en
Clinical efficacy of BG-12
@nl
P2093
P2860
P1433
P1476
Clinical efficacy of BG-12 (di ...... analyses of the CONFIRM study.
@en
P2093
David H Miller
J Theodore Phillips
John O'Gorman
Katherine T Dawson
Mariko Kita
Mark Novas
Robert J Fox
Vissia Viglietta
P2860
P2888
P304
P356
10.1007/S00415-013-6968-1
P577
2013-06-08T00:00:00Z